Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for multiple
hospital-and community-acquired infections, both in human and veterinary medicine. P …

Pseudomonas aeruginosa is the primary opportunistic human pathogen responsible for a
range of acute and chronic infections; it poses a significant threat to immunocompromised …

The Pseudomonas aeruginosa genome can change to adapt to different ecological niches.
We compared four genomes from a Mexican hospital and 59 genomes from GenBank from …

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections for which the
development of antibiotics is urgently needed. Unlike most enteric bacteria, P. aeruginosa …

Pseudomonas aeruginosa ST308 clone has been reported to carry carbapenemase genes
such as bla IMP and bla VIM but has been rarely associated with bla NDM-1. A total of 199 …

Introduction. The emergence of carbapenem-resistant Pseudomonas species producing
metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type …

Medical complications during pregnancy have been frequently reported from Western Africa
with a particular importance of infectious complications. Placental tissue can either become …

Objective (s): Production of metallo-β-lactamases (MBLs) is an important mechanism of
resistance to carbapenems. This study aimed to detect the MBL-producing Pseudomonas …

Pseudomonas aeruginosa (P. aeruginosa) is a major contributor of nosocomial infections.
The large and diverse gene pool and plastic genome enable it to exhibit significant diversity …

Antimicrobial resistance (AMR) is a global threat estimated to cause millions of deaths and
trillions of dollars in economic loss if not dealt with urgently. Carbapenems are one of the …